Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in china

Objective: The aim of this study was to investigate the cost-effectiveness of olaparib as the maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in China. Methods: A Markov model was developed to simulate the clinical course of typical patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Yamin, Liu, Yanxin, He, Xucheng, Ding, Yufeng, Zhang, Qilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411944/
https://www.ncbi.nlm.nih.gov/pubmed/36034834
http://dx.doi.org/10.3389/fphar.2022.818579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411944/
https://www.ncbi.nlm.nih.gov/pubmed/36034834
http://dx.doi.org/10.3389/fphar.2022.818579

Ejemplares similares